Quality Control Provisions (Trademark License Exhibit)
Drafts an exhibit to a Trademark License Agreement establishing quality standards, monitoring procedures, and compliance obligations that preserve the licensor's trademark rights under the Lanham Act, 15 U.S.C. § 1127.
Prerequisites
- Executed or draft Trademark License Agreement — defined terms, exhibit numbering, territory, licensed marks, product categories
- Brand standards / style guide — Pantone/CMYK values, approved mark forms, trademark designations (™ / ®)
- Approved pre-production samples (if any) — definitive quality benchmark
- Applicable regulatory framework — FDA, CPSC, FTC, or industry-specific standards
- Quality metrics — material specs, durability requirements, performance criteria
Quick Start
- Gather prerequisites above and confirm exhibit numbering with the main agreement
- Draft the seven sections below in order
- Adapt regulatory and quality-metrics content to the specific product category
- Cross-check all defined terms against the principal License Agreement
- Verify exhibit does not conflict with main agreement remedies or termination provisions
Document Header
| Element |
Content |
| Exhibit designation |
Next sequential letter/number per agreement structure |
| Title |
"Quality Control Standards and Procedures" |
| Integration clause |
Reference the Trademark License Agreement by date and parties; incorporate defined terms |
Core Sections
1. Foundational Quality Standards
- Applies to all products, services, packaging, and materials bearing the licensed marks
- State compliance is a material term of the Agreement
- Quality floor: meet or exceed quality of licensor's comparable products under the same marks
- Reference approved pre-production samples as the definitive benchmark
- Licensee bears sole regulatory responsibility; must maintain all licenses/permits; must promptly notify licensor of any regulatory inquiry or enforcement action
Include applicable regulatory requirements (FDA, CPSC, FTC, environmental, industry-specific) and quality metrics covering materials, workmanship, durability, performance, and aesthetics.
2. Trademark Usage Standards
- Marks displayed only in approved forms per brand standards manual
- Proper designations: ™ for common law, ® for registered
- No alteration without prior written consent
Prohibited uses: connection with unlawful/objectionable content, comparative advertising, registration of marks or confusingly similar variations, use in corporate/domain names without authorization, unauthorized sublicensing. All advertising and packaging require the same approval process as product samples.
3. Sample Submission & Approval
Scope: all items before production, distribution, or commercial use — finished products, packaging, labels, advertising/promotional materials, POS displays.
| Parameter |
Standard |
| Format |
Physical samples (3 per variation) and/or high-res digital |
| Lead time |
30–60 days before production/launch |
| Review period |
15–30 business days from complete submission |
| Approval form |
Written only; oral approvals insufficient |
Outcomes: Approve (may be conditional) · Request revisions · Reject. Approval does not waive inspection rights, is revocable if production materially differs, and both parties retain approved samples as the quality standard.
4. Inspection & Monitoring Rights
- Licensor may inspect licensee facilities on 5–10 business days' notice (immediate access for suspected material violations or safety concerns)
- Access to personnel, QC records, production logs, testing results
- Random sampling at no charge for lab/performance/safety testing
- Compliant inspection costs: licensor. Non-compliant inspection costs: licensee
- Licensee must maintain documented QC procedures, designate a QC officer, and submit periodic quality reports
5. Non-Compliance & Remediation
Graduated cure periods:
| Severity |
Cure Period |
Examples |
| Minor |
15–30 days |
Cosmetic deviations, minor labeling errors |
| Serious |
5–10 days |
Material quality shortfall, unapproved mark usage |
| Critical |
Immediate; no cure |
Safety defects, regulatory violations |
Adequate cure requires: corrective action plan approved by licensor, cessation of non-conforming production, destruction or rework of non-conforming inventory (documented), enhanced QC procedures, and new samples demonstrating correction.
Failure to cure triggers cumulative remedies: suspension, termination, monetary damages, injunctive relief.
6. Product Recall & Market Withdrawal
- Licensor may require immediate cessation and recall in its sole discretion
- Licensee obligations: notify distributors/retailers, consumer notification per licensor direction, establish return/refund process, retrieve and destroy recalled products (certified)
- All recall costs borne exclusively by Licensee
- Licensee indemnifies licensor from all claims arising from non-conforming products, quality deficiencies, regulatory violations, recalls, or breach of these provisions (survives termination)
7. Licensee Acknowledgments
Licensee expressly acknowledges:
- Quality control is essential to trademark validity under federal and state law
- Failure to control may result in trademark abandonment
- These provisions are material terms; material breach entitles licensor to immediate termination
- All goodwill vests exclusively in licensor
- Licensee will not challenge mark validity or claim ownership
- Upon termination, licensee retains no rights in marks or associated goodwill
Drafting Conventions
- "shall" for obligations, "may" for discretionary rights, "will" for future events
- Match defined terms exactly to the principal License Agreement; define new terms on first use
- Use numbered sections/subsections; avoid vague cross-references ("above," "herein")
- Incorporate industry standards (ISO, ASTM) by reference where applicable
- Include specific Pantone/CMYK values from brand guidelines where available
1---2name: quality-control-provisions3description: Drafts Quality Control Provisions as an exhibit to a Trademark License Agreement, covering quality standards, inspection rights, sample approval, non-compliance remedies, and recall obligations. Use when drafting trademark license QC exhibits, brand standards compliance annexes, or IP licensing quality schedules. Protects licensor rights and prevents abandonment under the Lanham Act.4---5
6# Quality Control Provisions (Trademark License Exhibit)
7
8Drafts an exhibit to a Trademark License Agreement establishing quality standards, monitoring procedures, and compliance obligations that preserve the licensor's trademark rights under the Lanham Act, 15 U.S.C. § 1127.
9
10## Prerequisites
11
121. **Executed or draft Trademark License Agreement** — defined terms, exhibit numbering, territory, licensed marks, product categories
132. **Brand standards / style guide** — Pantone/CMYK values, approved mark forms, trademark designations (™ / ®)
143. **Approved pre-production samples** (if any) — definitive quality benchmark
154. **Applicable regulatory framework** — FDA, CPSC, FTC, or industry-specific standards
165. **Quality metrics** — material specs, durability requirements, performance criteria
17
18## Quick Start
19
201. Gather prerequisites above and confirm exhibit numbering with the main agreement
212. Draft the seven sections below in order
223. Adapt regulatory and quality-metrics content to the specific product category
234. Cross-check all defined terms against the principal License Agreement
245. Verify exhibit does not conflict with main agreement remedies or termination provisions
25
26## Document Header
27
28| Element | Content |
29|---------|---------|
30| Exhibit designation | Next sequential letter/number per agreement structure |
31| Title | "Quality Control Standards and Procedures" |
32| Integration clause | Reference the Trademark License Agreement by date and parties; incorporate defined terms |
33
34## Core Sections
35
36### 1. Foundational Quality Standards
37
38- Applies to all products, services, packaging, and materials bearing the licensed marks
39- State compliance is a **material term** of the Agreement
40- Quality floor: meet or exceed quality of licensor's comparable products under the same marks
41- Reference approved pre-production samples as the definitive benchmark
42- Licensee bears sole regulatory responsibility; must maintain all licenses/permits; must promptly notify licensor of any regulatory inquiry or enforcement action
43
44Include applicable regulatory requirements (FDA, CPSC, FTC, environmental, industry-specific) and quality metrics covering materials, workmanship, durability, performance, and aesthetics.
45
46### 2. Trademark Usage Standards
47
48- Marks displayed only in approved forms per brand standards manual
49- Proper designations: ™ for common law, ® for registered
50- No alteration without prior written consent
51
52Prohibited uses: connection with unlawful/objectionable content, comparative advertising, registration of marks or confusingly similar variations, use in corporate/domain names without authorization, unauthorized sublicensing. All advertising and packaging require the same approval process as product samples.
53
54### 3. Sample Submission & Approval
55
56**Scope:** all items before production, distribution, or commercial use — finished products, packaging, labels, advertising/promotional materials, POS displays.
57
58| Parameter | Standard |
59|-----------|----------|
60| Format | Physical samples (3 per variation) and/or high-res digital |
61| Lead time | 30–60 days before production/launch |
62| Review period | 15–30 business days from complete submission |
63| Approval form | Written only; oral approvals insufficient |
64
65Outcomes: Approve (may be conditional) · Request revisions · Reject. Approval does not waive inspection rights, is revocable if production materially differs, and both parties retain approved samples as the quality standard.
66
67### 4. Inspection & Monitoring Rights
68
69- Licensor may inspect licensee facilities on **5–10 business days' notice** (immediate access for suspected material violations or safety concerns)
70- Access to personnel, QC records, production logs, testing results
71- Random sampling at no charge for lab/performance/safety testing
72- Compliant inspection costs: licensor. Non-compliant inspection costs: licensee
73- Licensee must maintain documented QC procedures, designate a QC officer, and submit periodic quality reports
74
75### 5. Non-Compliance & Remediation
76
77**Graduated cure periods:**
78
79| Severity | Cure Period | Examples |
80|----------|-------------|----------|
81| Minor | 15–30 days | Cosmetic deviations, minor labeling errors |
82| Serious | 5–10 days | Material quality shortfall, unapproved mark usage |
83| Critical | Immediate; no cure | Safety defects, regulatory violations |
84
85Adequate cure requires: corrective action plan approved by licensor, cessation of non-conforming production, destruction or rework of non-conforming inventory (documented), enhanced QC procedures, and new samples demonstrating correction.
86
87Failure to cure triggers cumulative remedies: suspension, termination, monetary damages, injunctive relief.
88
89### 6. Product Recall & Market Withdrawal
90
91- Licensor may require immediate cessation and recall in its sole discretion
92- Licensee obligations: notify distributors/retailers, consumer notification per licensor direction, establish return/refund process, retrieve and destroy recalled products (certified)
93- **All recall costs borne exclusively by Licensee**
94- Licensee indemnifies licensor from all claims arising from non-conforming products, quality deficiencies, regulatory violations, recalls, or breach of these provisions (survives termination)
95
96### 7. Licensee Acknowledgments
97
98Licensee expressly acknowledges:
991. Quality control is essential to trademark validity under federal and state law
1002. Failure to control may result in trademark abandonment
1013. These provisions are **material terms**; material breach entitles licensor to immediate termination
1024. All goodwill vests exclusively in licensor
1035. Licensee will not challenge mark validity or claim ownership
1046. Upon termination, licensee retains no rights in marks or associated goodwill
105
106## Drafting Conventions
107
108- "shall" for obligations, "may" for discretionary rights, "will" for future events
109- Match defined terms exactly to the principal License Agreement; define new terms on first use
110- Use numbered sections/subsections; avoid vague cross-references ("above," "herein")
111- Incorporate industry standards (ISO, ASTM) by reference where applicable
112- Include specific Pantone/CMYK values from brand guidelines where available